Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.
Identifieur interne : 000257 ( Main/Exploration ); précédent : 000256; suivant : 000258Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.
Auteurs : Malen Hollmann [Espagne] ; Olatz Garin ; Mariana Galante ; Montserrat Ferrer ; Angela Dominguez ; Jordi AlonsoSource :
- PloS one [ 1932-6203 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Années de vie ajustées sur la qualité (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (diagnostic), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Qualité de vie (MeSH), Sous-type H1N1 du virus de la grippe A (isolement et purification), Études de suivi (MeSH), Études longitudinales (MeSH).
- MESH :
- diagnostic : Grippe humaine.
- isolement et purification : Sous-type H1N1 du virus de la grippe A.
- épidémiologie : Espagne, Grippe humaine.
- Adulte, Adulte d'âge moyen, Années de vie ajustées sur la qualité, Femelle, Humains, Jeune adulte, Mâle, Qualité de vie, Études de suivi, Études longitudinales.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adult (MeSH), Female (MeSH), Follow-Up Studies (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza, Human (diagnosis), Influenza, Human (epidemiology), Longitudinal Studies (MeSH), Male (MeSH), Middle Aged (MeSH), Quality of Life (MeSH), Quality-Adjusted Life Years (MeSH), Spain (epidemiology), Young Adult (MeSH).
- MESH :
- geographic , epidemiology : Spain.
- diagnosis : Influenza, Human.
- epidemiology : Influenza, Human.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- Adult, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Quality of Life, Quality-Adjusted Life Years, Young Adult.
Abstract
BACKGROUND
We aimed to assess the changes in health-related quality of life (HRQL) in patients with confirmed diagnosis of influenza (H1N1)2009, and to estimate the individual and societal loss of quality-adjusted life years (QALYs) caused by the pandemic.
METHODS AND RESULTS
Longitudinal study of patients recruited at major hospitals and primary care centers in Spain. Patients reported their HRQL (EQ-5D) during their influenza episode and seven days prior to it. A subsample was monitored to evaluate HRQL after recovery. HRQL loss was estimated as the difference between EQ-5D prior to the influenza episode and during it. Individual QALY loss (disutility multiplied by the duration of the influenza episode in days) for confirmed cases was calculated and used to estimate the societal loss in Spain (with the official estimations). A total of 432 inpatients and 563 outpatients were included, of whom 145 and 184, respectively, were followed up. Baseline mean HRQL loss was 0.58 (95% CI, 0.53-0.63) for inpatients and 0.43 (95% CI, 0.40-0.46) for outpatients. The majority of the 145 inpatients and 184 outpatients who were followed up regained initial HRQL levels, presenting a mean difference of 0.01 between the EQ-5D score prior to and after the influenza episode. Individual QALY losses for inpatients (0.031, 95% CI, 0.025-0.037) were higher than for outpatients (0.009, 95% CI, 0.007-0.011), while societal QALY losses were reversed: 94 years for inpatients and 6,778 years for outpatients. For fatal cases (an official number of 318), we estimated a QALY loss of 11,981.
CONCLUSIONS
The influenza (H1N1)2009 pandemic had a significant but temporary impact on the HRQL of the majority of confirmed in- and outpatients. The societal impact of the influenza pandemic in Spain was estimated to be higher than other acute conditions. These results provide useful data for future cost-utility analyses.
DOI: 10.1371/journal.pone.0060477
PubMed: 23555979
PubMed Central: PMC3610925
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.</title><author><name sortKey="Hollmann, Malen" sort="Hollmann, Malen" uniqKey="Hollmann M" first="Malen" last="Hollmann">Malen Hollmann</name><affiliation wicri:level="3"><nlm:affiliation>Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Garin, Olatz" sort="Garin, Olatz" uniqKey="Garin O" first="Olatz" last="Garin">Olatz Garin</name></author><author><name sortKey="Galante, Mariana" sort="Galante, Mariana" uniqKey="Galante M" first="Mariana" last="Galante">Mariana Galante</name></author><author><name sortKey="Ferrer, Montserrat" sort="Ferrer, Montserrat" uniqKey="Ferrer M" first="Montserrat" last="Ferrer">Montserrat Ferrer</name></author><author><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Dominguez">Angela Dominguez</name></author><author><name sortKey="Alonso, Jordi" sort="Alonso, Jordi" uniqKey="Alonso J" first="Jordi" last="Alonso">Jordi Alonso</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23555979</idno><idno type="pmid">23555979</idno><idno type="doi">10.1371/journal.pone.0060477</idno><idno type="pmc">PMC3610925</idno><idno type="wicri:Area/Main/Corpus">00251</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00251</idno><idno type="wicri:Area/Main/Curation">000251</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000251</idno><idno type="wicri:Area/Main/Exploration">000251</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.</title><author><name sortKey="Hollmann, Malen" sort="Hollmann, Malen" uniqKey="Hollmann M" first="Malen" last="Hollmann">Malen Hollmann</name><affiliation wicri:level="3"><nlm:affiliation>Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Garin, Olatz" sort="Garin, Olatz" uniqKey="Garin O" first="Olatz" last="Garin">Olatz Garin</name></author><author><name sortKey="Galante, Mariana" sort="Galante, Mariana" uniqKey="Galante M" first="Mariana" last="Galante">Mariana Galante</name></author><author><name sortKey="Ferrer, Montserrat" sort="Ferrer, Montserrat" uniqKey="Ferrer M" first="Montserrat" last="Ferrer">Montserrat Ferrer</name></author><author><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Dominguez">Angela Dominguez</name></author><author><name sortKey="Alonso, Jordi" sort="Alonso, Jordi" uniqKey="Alonso J" first="Jordi" last="Alonso">Jordi Alonso</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Female (MeSH)</term><term>Follow-Up Studies (MeSH)</term><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term><term>Influenza, Human (diagnosis)</term><term>Influenza, Human (epidemiology)</term><term>Longitudinal Studies (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Quality of Life (MeSH)</term><term>Quality-Adjusted Life Years (MeSH)</term><term>Spain (epidemiology)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Années de vie ajustées sur la qualité (MeSH)</term><term>Espagne (épidémiologie)</term><term>Femelle (MeSH)</term><term>Grippe humaine (diagnostic)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Qualité de vie (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term><term>Études de suivi (MeSH)</term><term>Études longitudinales (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>Quality of Life</term><term>Quality-Adjusted Life Years</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Années de vie ajustées sur la qualité</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Qualité de vie</term><term>Études de suivi</term><term>Études longitudinales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>We aimed to assess the changes in health-related quality of life (HRQL) in patients with confirmed diagnosis of influenza (H1N1)2009, and to estimate the individual and societal loss of quality-adjusted life years (QALYs) caused by the pandemic.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS AND RESULTS</b></p><p>Longitudinal study of patients recruited at major hospitals and primary care centers in Spain. Patients reported their HRQL (EQ-5D) during their influenza episode and seven days prior to it. A subsample was monitored to evaluate HRQL after recovery. HRQL loss was estimated as the difference between EQ-5D prior to the influenza episode and during it. Individual QALY loss (disutility multiplied by the duration of the influenza episode in days) for confirmed cases was calculated and used to estimate the societal loss in Spain (with the official estimations). A total of 432 inpatients and 563 outpatients were included, of whom 145 and 184, respectively, were followed up. Baseline mean HRQL loss was 0.58 (95% CI, 0.53-0.63) for inpatients and 0.43 (95% CI, 0.40-0.46) for outpatients. The majority of the 145 inpatients and 184 outpatients who were followed up regained initial HRQL levels, presenting a mean difference of 0.01 between the EQ-5D score prior to and after the influenza episode. Individual QALY losses for inpatients (0.031, 95% CI, 0.025-0.037) were higher than for outpatients (0.009, 95% CI, 0.007-0.011), while societal QALY losses were reversed: 94 years for inpatients and 6,778 years for outpatients. For fatal cases (an official number of 318), we estimated a QALY loss of 11,981.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>The influenza (H1N1)2009 pandemic had a significant but temporary impact on the HRQL of the majority of confirmed in- and outpatients. The societal impact of the influenza pandemic in Spain was estimated to be higher than other acute conditions. These results provide useful data for future cost-utility analyses.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23555979</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>3</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.</ArticleTitle><Pagination><MedlinePgn>e60477</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0060477</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aimed to assess the changes in health-related quality of life (HRQL) in patients with confirmed diagnosis of influenza (H1N1)2009, and to estimate the individual and societal loss of quality-adjusted life years (QALYs) caused by the pandemic.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Longitudinal study of patients recruited at major hospitals and primary care centers in Spain. Patients reported their HRQL (EQ-5D) during their influenza episode and seven days prior to it. A subsample was monitored to evaluate HRQL after recovery. HRQL loss was estimated as the difference between EQ-5D prior to the influenza episode and during it. Individual QALY loss (disutility multiplied by the duration of the influenza episode in days) for confirmed cases was calculated and used to estimate the societal loss in Spain (with the official estimations). A total of 432 inpatients and 563 outpatients were included, of whom 145 and 184, respectively, were followed up. Baseline mean HRQL loss was 0.58 (95% CI, 0.53-0.63) for inpatients and 0.43 (95% CI, 0.40-0.46) for outpatients. The majority of the 145 inpatients and 184 outpatients who were followed up regained initial HRQL levels, presenting a mean difference of 0.01 between the EQ-5D score prior to and after the influenza episode. Individual QALY losses for inpatients (0.031, 95% CI, 0.025-0.037) were higher than for outpatients (0.009, 95% CI, 0.007-0.011), while societal QALY losses were reversed: 94 years for inpatients and 6,778 years for outpatients. For fatal cases (an official number of 318), we estimated a QALY loss of 11,981.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The influenza (H1N1)2009 pandemic had a significant but temporary impact on the HRQL of the majority of confirmed in- and outpatients. The societal impact of the influenza pandemic in Spain was estimated to be higher than other acute conditions. These results provide useful data for future cost-utility analyses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Malen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garin</LastName><ForeName>Olatz</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Galante</LastName><ForeName>Mariana</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Jordi</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="Y">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>02</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23555979</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0060477</ArticleId><ArticleId IdType="pii">PONE-D-12-21555</ArticleId><ArticleId IdType="pmc">PMC3610925</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qual Life Res. 2005 Aug;14(6):1523-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16110932</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Dec 8;480(7376):S2-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22158296</ArticleId></ArticleIdList></Reference><Reference><Citation>Aten Primaria. 2009 Jan;41(1):19-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19187838</ArticleId></ArticleIdList></Reference><Reference><Citation>Gac Sanit. 2009 Mar-Apr;23(2):104-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19442863</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 May 8;58(17):467-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19444150</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Jul 30;14(30):19286</Citation><ArticleIdList><ArticleId IdType="pubmed">19643058</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Jan 1;205(1):35-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22131338</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(12):e27777</Citation><ArticleIdList><ArticleId IdType="pubmed">22205927</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(2):e31696</Citation><ArticleIdList><ArticleId IdType="pubmed">22348122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Aug 8;374(9688):451-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19643469</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Nov 4;302(17):1896-902</Citation><ArticleIdList><ArticleId IdType="pubmed">19887665</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2010 Jan 18;192(2):84-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20078408</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Jan 14;15(2). pii: 19463</Citation><ArticleIdList><ArticleId IdType="pubmed">20085690</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol. 2010 Apr;115(4):717-26</Citation><ArticleIdList><ArticleId IdType="pubmed">20308830</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2010 Aug;19(6):853-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20354795</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2010 Aug;19(6):887-97</Citation><ArticleIdList><ArticleId IdType="pubmed">20401552</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2010 Aug;19(6):875-86</Citation><ArticleIdList><ArticleId IdType="pubmed">20405245</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Sep 23;15(38). pii: 19667</Citation><ArticleIdList><ArticleId IdType="pubmed">20929651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Salud Publica. 2010 Jul-Aug;84(4):353-69</Citation><ArticleIdList><ArticleId IdType="pubmed">21141264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Salud Publica. 2010 Sep-Oct;84(5):569-88</Citation><ArticleIdList><ArticleId IdType="pubmed">21203720</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Clin (Barc). 1999;112 Suppl 1:79-85</Citation><ArticleIdList><ArticleId IdType="pubmed">10618804</ArticleId></ArticleIdList></Reference><Reference><Citation>Commun Dis Public Health. 2000 Mar;3(1):32-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10743316</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 1999 Nov;44 Suppl B:11-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10877457</ArticleId></ArticleIdList></Reference><Reference><Citation>Aten Primaria. 2001 Oct 15;28(6):425-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11602124</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2001 Dec 1;33(11):1879-85</Citation><ArticleIdList><ArticleId IdType="pubmed">11692300</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2002 Sep 9;162(16):1842-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12196082</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2004 Mar;13(2):283-98</Citation><ArticleIdList><ArticleId IdType="pubmed">15085901</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2004 Mar 15;2:14</Citation><ArticleIdList><ArticleId IdType="pubmed">15023229</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Sep 15;292(11):1333-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15367555</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Data. 2004 Aug 26;(346):1-44</Citation><ArticleIdList><ArticleId IdType="pubmed">15460863</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Treat Rep. 1985 Oct;69(10):1155-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4042094</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Stat Q. 1992;45(2-3):306-11</Citation><ArticleIdList><ArticleId IdType="pubmed">1462665</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 1997 Oct;28(10):1883-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9341689</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2005;3:18</Citation><ArticleIdList><ArticleId IdType="pubmed">15780143</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2005;23(8):777-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16097840</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Salud Publica. 2010 Sep-Oct;84(5):589-96</Citation><ArticleIdList><ArticleId IdType="pubmed">21203721</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S50-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21342900</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(3):e17030</Citation><ArticleIdList><ArticleId IdType="pubmed">21399678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Salud Publica. 2011 Jan-Feb;85(1):3-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21750838</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Salud Publica. 2011 Jan-Feb;85(1):19-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21750839</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(7):e22308</Citation><ArticleIdList><ArticleId IdType="pubmed">21829456</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2011 Oct;26(7):428-35</Citation><ArticleIdList><ArticleId IdType="pubmed">21306876</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimers Dement. 2008 May;4(3):203-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18631969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement></list><tree><noCountry><name sortKey="Alonso, Jordi" sort="Alonso, Jordi" uniqKey="Alonso J" first="Jordi" last="Alonso">Jordi Alonso</name><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Dominguez">Angela Dominguez</name><name sortKey="Ferrer, Montserrat" sort="Ferrer, Montserrat" uniqKey="Ferrer M" first="Montserrat" last="Ferrer">Montserrat Ferrer</name><name sortKey="Galante, Mariana" sort="Galante, Mariana" uniqKey="Galante M" first="Mariana" last="Galante">Mariana Galante</name><name sortKey="Garin, Olatz" sort="Garin, Olatz" uniqKey="Garin O" first="Olatz" last="Garin">Olatz Garin</name></noCountry><country name="Espagne"><region name="Catalogne"><name sortKey="Hollmann, Malen" sort="Hollmann, Malen" uniqKey="Hollmann M" first="Malen" last="Hollmann">Malen Hollmann</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000257 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000257 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23555979
|texte= Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23555979" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |